David E Martin

Title: David E. Martin: Innovator in Pharmaceutical Compositions

Introduction: David E. Martin is an accomplished inventor based in Gaithersburg, MD, with a significant contribution to the pharmaceutical industry. With a focus on advancements in medical treatments, he holds one patent that highlights his innovative work in the field.

Latest Patents: Martin's patent relates to crystalline polymorphs of 3-O-(3',3′-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine salt (DSB•2NMG). This invention includes pharmaceutical compositions and their application as an active pharmaceutical agent for treating HIV-related disorders, showcasing Martin's commitment to addressing critical health challenges.

Career Highlights: David E. Martin is associated with Myrexis, Inc., a company known for its contributions to the development of novel pharmaceuticals. His role at the company emphasizes his dedication to creating impactful medical solutions that have the potential to improve patients' lives.

Collaborations: Throughout his career, Martin has collaborated with other professionals in the field, including colleagues Mike H. O'Neill and Gary G. Sweetapple. These collaborations reflect a team-oriented approach to innovation, emphasizing the importance of synergy in the pursuit of groundbreaking inventions.

Conclusion: David E. Martin's work exemplifies the spirit of innovation in the pharmaceutical sector. His patent and collaborations with notable professionals reveal his commitment to advancing medical science and improving treatment options for patients dealing with HIV-related disorders. His contributions at Myrexis, Inc. continue to reflect the positive impact of innovative thinking in healthcare.